Tue, March 3, 2020

Anupam Rama Maintained (BBIO) at Buy with Increased Target to $43 on, Mar 3rd, 2020

Anupam Rama of JP Morgan, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Increased Target from $38 to $43 on, Mar 3rd, 2020.

Anupam has made no other calls on BBIO in the last 4 months.



There is 1 other peer that has a rating on BBIO. Out of the 1 peers that are also analyzing BBIO, 0 agree with Anupam's Rating of Hold.



This is the rating of the analyst that currently disagrees with Anupam


  • Salim Syed of "Mizuho" Initiated at Strong Buy and Held Target at $51 on, Wednesday, February 19th, 2020